# MBIP

## Overview
MBIP (MAP3K12 binding inhibitory protein 1) is a gene that encodes a protein involved in the regulation of key cellular signaling pathways, particularly the JNK signaling pathway. The protein, MAP3K12 binding inhibitory protein 1, functions primarily as an inhibitor of MAP3K12, a kinase that activates the JNK pathway, which is crucial for processes such as stress response, apoptosis, and cellular differentiation (Tucker2008Molecular; Wang2008A). MBIP is predominantly localized in the cytoplasm and plays a significant role in brain development by influencing the migration of medial ganglionic eminence progenitors (Tucker2008Molecular). Additionally, MBIP is involved in histone modification, contributing to transcriptional regulation (Zencir2013Identification). Clinically, alterations in MBIP expression and function have been linked to various conditions, including benign hereditary chorea and certain cancers, highlighting its importance in both normal physiology and disease states (Invernizzi2018Benign; Yanchun2023MBIP).

## Function
MBIP (MAP3K12 binding inhibitory protein 1) is a protein that plays a crucial role in modulating the JNK signaling pathway by inhibiting MAP3K12, a kinase involved in activating this pathway. This regulation is significant in cellular processes such as stress responses, apoptosis, and differentiation (Tucker2008Molecular; Wang2008A). MBIP is primarily active in the cytoplasm, where it influences signaling cascades that affect cell survival and development (Wang2008A).

In the context of brain development, MBIP is involved in the migration patterns of medial ganglionic eminence (MGE) progenitors. It selectively inhibits the induction of JNK/SAPK activity by Map3k12, which is crucial for regulating cortical radial migration. This inhibition supports the tangential migration of MGE cells, maintaining their distinct migratory behavior in the developing forebrain (Tucker2008Molecular).

MBIP also plays a role in histone modification processes, which are essential for regulating gene expression. It is involved in the acetylation of histone H3 and H4, components of an ADA-containing HAT complex (ATAC), indicating its importance in transcriptional regulation (Zencir2013Identification).

## Clinical Significance
The MBIP gene (MAP3K12 binding inhibitory protein 1) has been implicated in several clinical conditions due to its role in cellular signaling pathways. In the context of benign hereditary chorea (BHC), a genomic deletion involving MBIP has been associated with symptoms such as hypotonia, motor delay, and hyperkinetic movement disorder. This deletion affects the expression of the NKX2-1 gene, mimicking haploinsufficiency caused by classical NKX2-1 mutations, and suggests a potential role for MBIP in the pathogenesis of brain-lung-thyroid syndrome (Invernizzi2018Benign).

MBIP is also involved in cancer, particularly esophageal squamous cell carcinoma (ESCC). High expression of MBIP in ESCC is linked to increased metastasis and poor prognosis. It promotes invasion and migration by inducing epithelial-mesenchymal transition (EMT) through the activation of the MAPK signaling pathway, specifically the JNK/p38 MAPK pathway. Knockdown of MBIP reduces these metastatic properties, highlighting its role as an oncogene in ESCC (Yanchun2023MBIP).

In thyroid cancer, MBIP is identified as a susceptibility gene, with its expression potentially influencing the JNK signaling pathway, which is involved in thyroid and other human cancers (Kulkarni2021Gene). These findings underscore the clinical significance of MBIP in various diseases.

## Interactions
MBIP (MAP3K12 binding inhibitory protein 1) is known for its interaction with MAP3K12, where it inhibits the kinase's ability to activate the JNK signaling pathway. This interaction is facilitated through leucine zipper-like motifs, which are crucial for the binding between MBIP and MAP3K12 (Tucker2008Molecular). MBIP's role in inhibiting MAP3K12 is significant in various cellular processes, including the regulation of the JNK pathway, which is involved in stress responses and apoptosis (Inglés2019Relation).

In the context of breast cancer, MBIP is implicated in the inactivation of the mitogen-activated protein kinase (MAPK) pathway, with specific single-nucleotide polymorphisms (SNPs) altering its function in this pathway (Lee2014Genomewide). This suggests a potential role for MBIP in modulating signaling pathways that contribute to cancer susceptibility.

Additionally, MBIP is part of the NK2 homeobox 1 complex, which is essential for the expression of thyroid-specific genes, indicating its involvement in thyroid function regulation (Kuś2020The). Although specific interactions with nucleic acids are not detailed, MBIP's interactions with proteins like MAP3K12 highlight its role in critical signaling pathways.


## References


[1. (Zencir2013Identification) Sevil Zencir, Adam Sike, Melanie J. Dobson, Ferhan Ayaydin, Imre Boros, and Zeki Topcu. Identification of transcriptional and phosphatase regulators as interaction partners of human ada3, a component of histone acetyltransferase complexes. Biochemical Journal, 450(2):311–320, February 2013. URL: http://dx.doi.org/10.1042/bj20120452, doi:10.1042/bj20120452. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20120452)

[2. (Wang2008A) Min Wang, Dirk Windgassen, and Eleftherios T Papoutsakis. A global transcriptional view of apoptosis in human t-cell activation. BMC Medical Genomics, October 2008. URL: http://dx.doi.org/10.1186/1755-8794-1-53, doi:10.1186/1755-8794-1-53. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1755-8794-1-53)

[3. (Kulkarni2021Gene) Om Kulkarni, Pierre-Emmanuel Sugier, Julie Guibon, Anne Boland-Augé, Christine Lonjou, Delphine Bacq-Daian, Robert Olaso, Carole Rubino, Vincent Souchard, Frédérique Rachedi, Juan Jesus Lence-Anta, Rosa Maria Ortiz, Constance Xhaard, Pierre Laurent-Puig, Claire Mulot, Anne-Valérie Guizard, Claire Schvartz, Marie-Christine Boutron-Ruault, Evgenia Ostroumova, Ausrele Kesminiene, Jean-François Deleuze, Pascal Guénel, Florent De Vathaire, Thérèse Truong, and Fabienne Lesueur. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma. Scientific Reports, April 2021. URL: http://dx.doi.org/10.1038/s41598-021-88253-0, doi:10.1038/s41598-021-88253-0. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-88253-0)

4. (Yanchun2023MBIP) MBIP promotes ESCC metastasis by activating MAPK pathway. This article has 0 citations.

[5. (Lee2014Genomewide) Young Ho Lee, Jae-Hoon Kim, and Gwan Gyu Song. Genome-wide pathway analysis of breast cancer. Tumor Biology, 35(8):7699–7705, May 2014. URL: http://dx.doi.org/10.1007/s13277-014-2027-5, doi:10.1007/s13277-014-2027-5. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13277-014-2027-5)

[6. (Tucker2008Molecular) Eric S. Tucker, Samantha Segall, Deepak Gopalakrishna, Yongqin Wu, Mike Vernon, Franck Polleux, and Anthony-Samuel LaMantia. Molecular specification and patterning of progenitor cells in the lateral and medial ganglionic eminences. The Journal of Neuroscience, 28(38):9504–9518, September 2008. URL: http://dx.doi.org/10.1523/JNEUROSCI.2341-08.2008, doi:10.1523/jneurosci.2341-08.2008. This article has 56 citations.](https://doi.org/10.1523/JNEUROSCI.2341-08.2008)

[7. (Invernizzi2018Benign) Federica Invernizzi, Giovanna Zorzi, Andrea Legati, Giovanni Coppola, Pio D’Adamo, Nardo Nardocci, Barbara Garavaglia, and Daniele Ghezzi. Benign hereditary chorea and deletions outside nkx2-1: what’s the role of mbip? European Journal of Medical Genetics, 61(10):581–584, October 2018. URL: http://dx.doi.org/10.1016/j.ejmg.2018.03.011, doi:10.1016/j.ejmg.2018.03.011. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2018.03.011)

[8. (Inglés2019Relation) Marta Inglés, Cristina Mas-Bargues, Lucia Gimeno-Mallench, Raquel Cruz-Guerrero, Francisco J. García-García, Juan Gambini, Consuelo Borrás, Leocadio Rodríguez-Mañas, and Jose Viña. Relation between genetic factors and frailty in older adults. Journal of the American Medical Directors Association, 20(11):1451–1457, November 2019. URL: http://dx.doi.org/10.1016/j.jamda.2019.03.011, doi:10.1016/j.jamda.2019.03.011. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jamda.2019.03.011)

[9. (Kuś2020The) Aleksander Kuś, Layal Chaker, Alexander Teumer, Robin P Peeters, and Marco Medici. The genetic basis of thyroid function: novel findings and new approaches. The Journal of Clinical Endocrinology &amp; Metabolism, 105(6):1707–1721, April 2020. URL: http://dx.doi.org/10.1210/clinem/dgz225, doi:10.1210/clinem/dgz225. This article has 28 citations.](https://doi.org/10.1210/clinem/dgz225)